Element Materials Technology at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Element Materials Technology brings 22 presentations to IDWeek 2026 in Washington. Its program centres on how new antibacterial and antifungal agents perform in the laboratory against resistant bacteria, yeasts and molds collected from US and global medical centers. Agents covered include aztreonam-avibactam, cefiderocol-xeruborbactam and manogepix, tested against carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Aspergillus.
| Organization | IDWeek 2026 Attendance |
|---|---|
Testing and certification company whose Jones Microbiology Institute, formerly JMI Laboratories, runs antimicrobial surveillance and susceptibility testing. | Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Enterobacterales, Including Molecularly Characterized Isolates Recovered Globally in 2024 Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Global Acinetobacter baumannii-calcoaceticus species complex Isolates Poster Thu Oct 22 12:15pm–1:30pm Activity of Cefiderocol-Xeruborbactam and Comparator Agents against Pseudomonas aeruginosa, Including Molecularly Characterized Isolates Recovered Globally in 2024 Poster Thu Oct 22 12:15pm–1:30pm Activity of Ceftazidime-Avibactam against Pseudomonas aeruginosa from Patients with Ventilator-Associated Pneumonia (VAP) from United States Medical Centers (2021-2025). Poster Thu Oct 22 12:15pm–1:30pm Activity of Fosfomycin against Enterobacterales Collected from US Medical Centers during 2020-2023 Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against Aspergillus spp. isolates with CYP51 alterations Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against mold isolates across geographic regions Poster Thu Oct 22 12:15pm–1:30pm Activity of manogepix against yeast and mold isolates from 2025 in the United States Poster Thu Oct 22 12:15pm–1:30pm Activity of rezafungin against Aspergillus spp. that are non-wild-type to azole antifungal agents Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Activity of Aztreonam-Avibactam against Enterobacterales Isolated from Patients with Ventilator-Associated Pneumonia (VAP) Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Susceptibility and Molecular Characterization of Carbapenem-Resistant Klebsiella pneumoniae from United States Medical Centers (2020-2025) Poster Thu Oct 22 12:15pm–1:30pm Antimicrobial Susceptibility of KPC-Producing Enterobacterales and Molecular Characterization of Ceftazidime-Avibactam-Resistant Strains from United States Medical Centers (2018-2025). Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-Avibactam Activity against Carbapenem-Resistant Enterobacterales from United States Medical Centers Stratified By year and Resistance Mechanism (2021-2025). Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-Avibactam Activity against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in United States Medical Centers (2023–2025) Poster Thu Oct 22 12:15pm–1:30pm Aztreonam-avibactam activity against Enterobacterales from United States medical centers: Summary of 5 years of surveillance prior to approval for clinical use (2020-2024) Poster Thu Oct 22 12:15pm–1:30pm In vitro Activity of Cefiderocol (FDC) Against a Collection of Infrequently Isolated Gram-Negative Bacterial Isolates from the SENTRY Antimicrobial Surveillance Program Poster Thu Oct 22 12:15pm–1:30pm In vitro Activity of Ceftobiprole and Comparator Agents Against Contemporary US Clinical Isolates Collected in 2025 Following FDA Approval Poster Thu Oct 22 12:15pm–1:30pm Reproducibility of Cefiderocol-Xeruborbactam MIC Determinations in Cation Adjusted Mueller Hinton Broth and Iron Depleted CAMHB using Two Reading Endpoints Talk Fri Oct 23 12:25pm–12:30pm Aztreonam-Avibactam Activity against Carbapenem-Resistant Enterobacterales from United States Medical Centers Stratified By year and Resistance Mechanism (2021-2025). Antimicrobials, resistance and stewardship Talk Fri Oct 23 4:15pm–4:30pm Activity of manogepix against Candida auris isolates from the United States Antimicrobials, resistance and stewardship Poster Sat Oct 24 12:15pm–1:30pm Activity of Omadacycline and Comparators Against Common Microbial Contaminants: Cronobacter sakazakii, Pluralibacter gergoviae, and Burkholderia cepacia species complex isolates Poster Sat Oct 24 12:15pm–1:30pm In Vitro Activity of Omadacycline against 7,200 Bacterial Clinical Isolates Representing Multiple Infection Types from the United States (2024-2025) |
Instantly find 20 buyers from Element Materials Technology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction